| Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ... Journal of the National cancer Institute 103 (22), 1656-1664, 2011 | 2139 | 2011 |
| American cancer society/American society of clinical oncology breast cancer survivorship care guideline CD Runowicz, CR Leach, NL Henry, KS Henry, HT Mackey, ... Journal of clinical oncology 34 (6), 611-635, 2016 | 1792 | 2016 |
| Cancer biomarkers NL Henry, DF Hayes Molecular oncology 6 (2), 140-146, 2012 | 1072 | 2012 |
| Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update JL Khatcheressian, P Hurley, E Bantug, LJ Esserman, E Grunfeld, ... Journal of Clinical Oncology 31 (7), 961-965, 2013 | 741 | 2013 |
| Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population H Korkaya, G Kim, A Davis, F Malik, NL Henry, S Ithimakin, AA Quraishi, ... Molecular cell 47 (4), 570-584, 2012 | 600 | 2012 |
| Molecular heterogeneity and response to neoadjuvant human epidermal growth factor receptor 2 targeting in CALGB 40601, a randomized phase III trial of paclitaxel plus … LA Carey, DA Berry, CT Cirrincione, WT Barry, BN Pitcher, LN Harris, ... Journal of clinical oncology 34 (6), 542-549, 2016 | 420 | 2016 |
| Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer NL Henry, F Azzouz, Z Desta, L Li, AT Nguyen, S Lemler, J Hayden, ... Journal of Clinical Oncology 30 (9), 936-942, 2012 | 404 | 2012 |
| Effect of acupuncture vs sham acupuncture or waitlist control on joint pain related to aromatase inhibitors among women with early-stage breast cancer: a randomized clinical trial DL Hershman, JM Unger, H Greenlee, JL Capodice, DL Lew, AK Darke, ... Jama 320 (2), 167-176, 2018 | 305 | 2018 |
| Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors NL Henry, JT Giles, D Ang, M Mohan, D Dadabhoy, J Robarge, J Hayden, ... Breast cancer research and treatment 111, 365-372, 2008 | 270 | 2008 |
| Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: ASCO clinical practice guideline update—integration of … F Andre, N Ismaila, NL Henry, MR Somerfield, RC Bast, W Barlow, ... Journal of Clinical Oncology 37 (22), 1956-1964, 2019 | 266 | 2019 |
| Biomarkers for adjuvant endocrine and chemotherapy in early-stage breast cancer: ASCO guideline update F Andre, N Ismaila, KH Allison, WE Barlow, DE Collyar, S Damodaran, ... Journal of Clinical Oncology 40 (16), 1816-1837, 2022 | 261 | 2022 |
| Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes Q Kang, NL Henry, C Paoletti, H Jiang, P Vats, AM Chinnaiyan, DF Hayes, ... Clinical biochemistry 49 (18), 1354-1360, 2016 | 210 | 2016 |
| Sex differences in risk of severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in cancer clinical trials JM Unger, R Vaidya, KS Albain, M LeBlanc, LM Minasian, CC Gotay, ... Journal of Clinical Oncology 40 (13), 1474-1486, 2022 | 206 | 2022 |
| Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation C Cutler, NL Henry, C Magee, S Li, HT Kim, E Alyea, V Ho, SJ Lee, ... Biology of Blood and Marrow Transplantation 11 (7), 551-557, 2005 | 196 | 2005 |
| Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer NL Henry, DF Hayes The oncologist 11 (6), 541-552, 2006 | 187 | 2006 |
| Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor–positive breast cancer C Paoletti, MC Muñiz, DG Thomas, KA Griffith, KM Kidwell, N Tokudome, ... Clinical Cancer Research 21 (11), 2487-2498, 2015 | 138 | 2015 |
| Drug interactions and pharmacogenomics in the treatment of breast cancer and depression NL Henry, V Stearns, DA Flockhart, DF Hayes, M Riba American Journal of Psychiatry 165 (10), 1251-1255, 2008 | 138 | 2008 |
| International Ki-67 in Breast Cancer Working Group Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ... J Natl Cancer Inst 103 (22), 1656-1664, 2011 | 114 | 2011 |
| Role of patient and disease factors in adjuvant systemic therapy decision making for early-stage, operable breast cancer: American Society of Clinical Oncology endorsement of … NL Henry, MR Somerfield, VG Abramson, KH Allison, CK Anders, ... Journal of Clinical Oncology 34 (19), 2303-2311, 2016 | 113 | 2016 |
| Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and Age Z Desta, Y Kreutz, AT Nguyen, L Li, T Skaar, LK Kamdem, NL Henry, ... Clinical Pharmacology & Therapeutics 90 (5), 693-700, 2011 | 113 | 2011 |
